Figures & data
Figure 1 Areas of BMDJ and FDOJ.
![Figure 1 Areas of BMDJ and FDOJ.](/cms/asset/3998f86c-d083-40fa-9b7e-025dbd85e5c1/dnnd_a_12173815_f0001_c.jpg)
Figure 2 Excision of BMDJ and FDOJ.
![Figure 2 Excision of BMDJ and FDOJ.](/cms/asset/bbb53503-e3e9-4da0-97e4-fa66be0130ff/dnnd_a_12173815_f0002_c.jpg)
Figure 3 Comparison of cytokines in BMDJ/FDOJ versus normal cancellous bone.
![Figure 3 Comparison of cytokines in BMDJ/FDOJ versus normal cancellous bone.](/cms/asset/082bb578-f035-401c-9d29-4a1db5ba46bf/dnnd_a_12173815_f0003_c.jpg)
Figure 4 R/C overexpression in BMDJ/FDOJ.
![Figure 4 R/C overexpression in BMDJ/FDOJ.](/cms/asset/96ea4b26-19be-4ef6-9b11-71fa493e49c5/dnnd_a_12173815_f0004_c.jpg)
Figure 5 Histological findings from BMDJ/FDOJ-MS samples (n=17).
![Figure 5 Histological findings from BMDJ/FDOJ-MS samples (n=17).](/cms/asset/e69c62c1-3c96-409e-948f-4c78e9bdd097/dnnd_a_12173815_f0005_c.jpg)
Figure 6 Comparison of cytokines in BMDJ/FDOJ in an MS patient versus healthy controls.
![Figure 6 Comparison of cytokines in BMDJ/FDOJ in an MS patient versus healthy controls.](/cms/asset/59399233-b928-48c1-811d-d0fa1e3aaa76/dnnd_a_12173815_f0006_c.jpg)
Figure 7 Comparison of the expression of seven cytokines in BMDJ/FDOJ in an MS patient versus the control group.
![Figure 7 Comparison of the expression of seven cytokines in BMDJ/FDOJ in an MS patient versus the control group.](/cms/asset/9d10ea8e-bf5c-4f3e-8ea4-2510d82cddfd/dnnd_a_12173815_f0007_c.jpg)
Figure 8 Comparison of R/C expression in the CSF and areas of FDOJ in MS patients.
![Figure 8 Comparison of R/C expression in the CSF and areas of FDOJ in MS patients.](/cms/asset/b7d1fdac-a825-47b7-9115-77740f1231fd/dnnd_a_12173815_f0008_c.jpg)
Figure 9 Comparison of R/C expression in serum in MS patients in the literature versus the cohort with areas of FDOJ.
![Figure 9 Comparison of R/C expression in serum in MS patients in the literature versus the cohort with areas of FDOJ.](/cms/asset/cd83f7a4-4325-423a-b0ee-27359758e370/dnnd_a_12173815_f0009_c.jpg)